Altfest L J & CO Inc Denali Therapeutics Inc. Transaction History

Altfest L J & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$42.59 - $55.02 $211,331 - $273,009	-4,962 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$48.48 - $78.23 $43,535 - $70,250	898 Added 22.1%	4,962 $250,000
Q2 2021 Jul 28, 2021	BUY	$50.3 - $78.44 $2,917 - $4,549	58 Added 1.45%	4,064 $319,000
Q1 2021 May 07, 2021	BUY	$53.8 - $81.53 $215,522 - $326,609	4,006 New	4,006 $229,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.56B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Altfest L J & CO Inc with notifications on news.